Professor Nils Hoppe
Nils is a solicitor and the partner lead on regulatory and compliance practice.
Nils is also the professor of law and ethics in the life sciences at the University of Hannover, and Dean of Research. After graduating in law, with a specialisation in medical law and human rights law, Nils first worked in insurance litigation at Browne Jacobson LLP, and later as in-house counsel at a university hospital.
He has been an ethics expert to the European Commission since 2008, advises various governments on novel health technologies and governance frameworks, and served on the UK Biobank Ethics and Governance Council from 2014-2018. Nils has advised biobanks, large-scale research clusters, and clinical trials with a particular focus on research governance, consent aspects, and cross-border issues. He also provides advice on ethical issues in biomedical research and innovation, and has assisted in tricky applications to research ethics committees, animal welfare committees, and institutional review boards.
Nils took his undergraduate degree (LL.B.) at Nottingham Law School, and a certificate in European technology and business law from Erlangen. He was awarded a doctorate in law, with a thesis on biotechnology law (magna cum laude), from Hannover Law School. He also holds a qualification in international arbitration and originally trained as a barrister (but was not called to the Bar). He was a consultant lawyer at Hill Dickinson LLP until he founded LDMH with James.
Qualifications
- Certificate in European Business and Technology Law, Erlangen University (1999)
- LL.B. (Europe), Nottingham Law School (2000)
- Dr. iur. (Law), Faculty of Law, Hannover University (2008)
- ACIArb (International Arbitration) (2015)
Memberships & Affiliations
- Law Society (since 2025)
- The Honourable Society of Gray’s Inn (until 2024)
- New York State Bar Association (until 2024)
- Coram Chambers (Associate Member)
- Chartered Institute of Arbitrators (Associate, until 2024)
- European Association of Health Law (Member)
- Royal Society of Medicine (Fellow, until 2023)
- Editorial Board of the Medical Law Review (Member)
Selected Publications
Nils has over 50 publications in the fields of ethics and law in the life sciences. Here is a selection of the most recent / relevant publications:
- Hoppe, N. & Rensten, K. (2015): Mitochondrial Donation, Family Law Week, (Online) 17 Feb 2015
- van der Boon, R. M. A., Camm, A. J., Aguiar, C., Biassin, E., Breithardt, G., Bueno, H., Drossart, I., Hoppe, N., Kamenjasevic, E., Ladeiras-Lopes, R., McrGreavy, P., Lanzer, P., Vidal-Perez, R., & Bruining, N. (2024): Risks and Benefits of Sharing Patient Information on Social Media: A Digital Dilemma, European Heart Journal – Digital Health, 1–9. DOI: 10.1093/ehjdh/ztae009
- Hoppe, N., & Miola, J. (2022): The Burden of History: How Past Scandals Have Shaped the Future Governance of Human Tissue and Health Data, In: E. Dove & N. Nic Shuibhne (Eds.), Law and Legacy in Medical Jurisprudence: Essays in Honour of Graeme Laurie (pp. 190-208). Cambridge: Cambridge University Press. DOI: 10.1017/9781108903295.011
- Erikainen, S., Friesen, P., Rand, L., Jongsma, K., Dunn, M., Sorbie, A., McCoy, M., Bell, J., Burgess, M., Chen, H., Chico, V., Cunningham-Burley, S., Darbyshire, J., Dawson, R., Evans, A., Fahy, N., Finlay, T., Frith, L., Goldenberg, A., … Hoppe, N., … Sheehan, M. (2021): Public involvement in the governance of population-level biomedical research: Unresolved questions and future directions, Journal of Medical Ethics, 47(7), 522-525. DOI: 10.1136/medethics-2020-106530
- Hoppe, N., Cantz, T., & Kwisda, K. (2021): Regulatory and intellectual property conundrums surrounding xenotransplantation, Nature Biotechnology 39, 796–798. DOI: 10.1038/s41587-021-00976-7
Contact Nils
LDMH Partners Ltd.
Blake House, 18 Blake Street
York YO1 8QG, England
Tel.: +44 (0)1904 900 915
LDMH Partners GmbH
Hannover Docks, Eichenbrink 5
30453 Hannover, Germany
Tel.: +49 (0)511 5154 622 0
E-Mail: nils.hoppe@ldmh.eu
Please read our Privacy Policy to see how we use your data when you get in touch with us.
